| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $15.4M | $15.4M | $15.9M |
| YoY Revenue Growth % | +0.2% | -3.3% | — |
| Gross Profit | $10.2M | $10.4M | — |
| Gross Margin % | 66.6% | 67.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.4M | -$2.0M | -$9.9M |
| Operating Margin % | -15.8% | -13.1% | -62.4% |
| Net Income (GAAP) | -$2.5M | -$2.0M | -$9.4M |
| EBITDA (Normalized) | -$2.4M | -$2.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.1M | -$765.0K | $277.0K |
| Capital Expenditures (CapEx) | $18.0K | $29.0K | — |
| Free Cash Flow (FCF) | -$1.1M | -$794.0K | $277.0K |
| FCF Margin % | -7.3% | -5.2% | 1.7% |
| Return on Invested Capital (ROIC %) | -23.3% | -19.8% | — |
| Cash & Short-Term Equivalents | $1.5M | $1.5M | — |
| Total Debt (Short + Long Term) | $150.0K | — | — |
| Total Stockholders' Equity | $9.6M | $9.6M | — |